Medgenics Announces New Executive Leadership Team
September 16 2013 - 7:30AM
Business Wire
New team includes President and CEO Michael
Cola formerly with Shire and Safeguard Scientifics, CFO John Leaman
formerly with Shire and McKinsey, and Global Head of R&D Garry
Neil formerly with Apple Tree Partners and Johnson &
Johnson
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Jul 2023 to Jul 2024